Core Laboratories Nv Stock Today

CLB Stock  USD 20.41  0.14  0.68%   

Performance

3 of 100

 
Weak
 
Strong
Insignificant

Odds Of Distress

Less than 1

 
High
 
Low
Very Small
Core Laboratories is trading at 20.41 as of the 28th of November 2024, a 0.68 percent down since the beginning of the trading day. The stock's open price was 20.55. Core Laboratories has a very small chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Core Laboratories NV are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of September 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain
Energy
IPO Date
20th of September 1995
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. The company has 46.95 M outstanding shares of which 6.95 M shares are currently shorted by investors with about 21.39 days to cover. More on Core Laboratories NV

Moving together with Core Stock

  0.8TS Tenaris SA ADRPairCorr
  0.73DNOW Now IncPairCorr

Moving against Core Stock

  0.48XPRO Expro Group HoldingsPairCorr
  0.44TDW TidewaterPairCorr
  0.33ENSV EnservcoPairCorr
  0.31DTI Drilling Tools InterPairCorr

Core Stock Highlights

ESG Sustainability
Environmental
Governance
Social
ChairmanLawrence Bruno
Thematic IdeaPetroleum and Natural Gas (View all Themes)
Old Names[ATEX Resources Inc, Core Laboratories NV, Candy Club Holdings Ltd]
Business ConcentrationOil & Gas Equipment & Services, Energy, NYSE Composite, PHLX Oil Service, SP Small-Cap 600, Petroleum and Natural Gas, Energy, Energy Equipment & Services, Oil & Gas Equipment & Services, Energy (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.890.8694
Fairly Up
Slightly volatile
Gross Profit Margin0.20.1845
Significantly Up
Slightly volatile
Net Debt187 M200.3 M
Significantly Down
Pretty Stable
Total Current Liabilities100.6 M88.1 M
Fairly Up
Very volatile
Non Current Liabilities Total267.2 M268.5 M
Slightly Down
Pretty Stable
Total Assets550.2 M586.4 M
Notably Down
Pretty Stable
Total Current Assets225 M223.1 M
Slightly Up
Very volatile
Total Cash From Operating Activities23.5 M24.8 M
Notably Down
Slightly volatile
Debt Levels
Core Laboratories can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Core Laboratories' financial leverage. It provides some insight into what part of Core Laboratories' total assets is financed by creditors.
Liquidity
Core Laboratories NV has 215.38 M in debt with debt to equity (D/E) ratio of 1.29, which is OK given its current industry classification. Core Laboratories has a current ratio of 2.19, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Core to invest in growth at high rates of return.

Change To Inventory

(12.33 Million)
Core Laboratories NV (CLB) is traded on New York Stock Exchange in USA. It is located in 6316 Windfern Road, Houston, TX, United States, 77040 and employs 3,500 people. Core Laboratories is listed under Oil & Gas Equipment & Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 964.82 M. Core Laboratories runs under Energy Equipment & Services sector within Energy industry. The entity has 46.95 M outstanding shares of which 6.95 M shares are currently shorted by investors with about 21.39 days to cover. Core Laboratories NV has about 15.43 M in cash with 24.79 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.29.
Check Core Laboratories Probability Of Bankruptcy
Ownership Allocation
The majority of Core Laboratories NV outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Core Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Core Laboratories. Please pay attention to any change in the institutional holdings of Core Laboratories NV as this could imply that something significant has changed or is about to change at the company.
Check Core Ownership Details

Core Stock Institutional Holders

InstituionRecorded OnShares
Dimensional Fund Advisors, Inc.2024-09-30
819.6 K
Btim Corp2024-09-30
600.8 K
Van Eck Associates Corporation2024-06-30
539.9 K
Fred Alger Management, Llc2024-09-30
535.9 K
Charles Schwab Investment Management Inc2024-09-30
529.5 K
Bank Of New York Mellon Corp2024-06-30
516.1 K
Northern Trust Corp2024-09-30
499.6 K
Gendell Jeffrey L2024-09-30
460.7 K
Wayne Hummer Investments Llc2024-06-30
382.1 K
Ariel Investments, Llc2024-09-30
10 M
Blackrock Inc2024-06-30
7.8 M
View Core Laboratories Diagnostics

Core Laboratories Historical Income Statement

At present, Core Laboratories' Depreciation And Amortization is projected to decrease significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 619.3 M, whereas Interest Expense is forecasted to decline to about 10.1 M. View More Fundamentals

Core Stock Against Markets

Core Laboratories Corporate Management

Gwendolyn MBASenior RelationsProfile
J DumasVice President Business DevelopmentProfile
Martha CarnesPresiding Non-Executive Lead Independent Member of the Supervisory BoardProfile
Monique EeuwijkNon-Executive Independent Member of the Supervisory BoardProfile
Jacobus SchoutenManaging DirectorProfile
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Oil & Gas Equipment & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.316
Dividend Share
0.04
Earnings Share
0.54
Revenue Per Share
11.158
Quarterly Revenue Growth
0.072
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.